Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Reviews in Endocrine and Metabolic Disorders
Literature
1.
Leonhardt W, Hanefeld M, Julius U, Haller H. Significance of fatty tissue hypertrophy for the metabolic risk. Z Gesamte Inn Med. 1977;32((12):suppl):186–7.PubMed
2.
Hanefeld M, Leonhardt W. Das Metabolische Syndrom. Deutsche Gesundheitswesen. 1981;36:545–51.
3.
Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia. 1996;39(12):1577–83.CrossRefPubMed
4.
Hanefeld M, Schmechel H, Schwanebeck U, Lindner J. Predictors of coronary heart disease and death in NIDDM: the Diabetes Intervention Study experience. Diabetologia. 1997;40 Suppl 2:S123–4.CrossRefPubMed
5.
Hanefeld M, Pistrosch F, Koehler C, Chiasson JL. Conversion of IGT to type 2 diabetes mellitus is associated with incident cases of hypertension: a post-hoc analysis of the STOP-NIDDM trial. J Hypertens. 2012;30(7):1440–3.CrossRefPubMed
6.
Hanefeld M, Karasik A, Koehler C, Westermeier T, Chiasson JL. Metabolic syndrome and its single traits as risk factors for diabetes in people with impaired glucose tolerance: the STOP-NIDDM trial. Diab Vasc Dis Res. 2009;6(1):32–7.CrossRefPubMed
7.
Hanefeld M, Koehler C, Henkel E, Fuecker K, Schaper F, Temelkova-Kurktschiev T. Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes. Diabet Med. 2000;17(12):835–40.CrossRefPubMed
8.
Stahn A, Pistrosch F, Ganz X, Teige M, Koehler C, Bornstein S, et al. Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmias. Diabetes Care. 2014;37(2):516–20.CrossRefPubMed
9.
Pistrosch F, Ganz X, Bornstein SR, Birkenfeld AL, Henkel E, Hanefeld M. Risk of and risk factors for hypoglycemia and associated arrhythmias in patients with type 2 diabetes and cardiovascular disease: a cohort study under real-world conditions. Acta Diabetol. 2015;52(5):889–95.CrossRefPubMed
10.
Hanefeld M, Pistrosch F, Bornstein SR, Birkenfeld AL. The metabolic vascular syndrome – guide to an individualized treatment. Rev Endocr Metab Disord. 2016.
11.
Jordan J, Birkenfeld AL. Cardiometabolic crosstalk in obesity-associated arterial hypertension. Rev Endocr Metab Disord. 2016.
12.
Endocrine Hypertension. In: Koch CA, Chrousos GP, editors. Contemporary Endocrinology Series. Springer, New York; 2013. ISBN: 978-1-60761-547-7 (Print), ISBN-10: 978-1-60761-548-4 (online).
13.
Nati M, Haddad D, Birkenfeld AL, Koch CA, Chavakis T, Chatzigeorgiou A. The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). Rev Endocr Metab Disord. 2016.
14.
Alexaki VI, Chavakis T. The role of innate immunity in the regulation of brown and beige adipogenesis. Rev Endocr Metab Disord. 2016.
15.
Siegel-Axel DI, Häring HU. Perivascular adipose tissue: an unique fat compartment relevant for the cardiometabolic syndrome. Rev Endocr Metab Disord. 2016.
16.
Dalgaard K, Landgraf K, Heyne S, Lempradl A, Longinotto J, Gossens K, et al. Trim28 Haploinsufficiency Triggers Bi-stable epigenetic obesity. Cell. 2016;164(3):353–64.CrossRefPubMedPubMedCentral
17.
Turner JB, Kumar A, Koch CA. The effects of indoor and outdoor temperature on metabolic rate and adipose tissue – The Mississipppi perspective on the obesity epidemic. Rev Endocr Metab Disord. 2016, in press.
18.
Lebovitz HE. Interventional treatment of obesity and diabetes: an interim report on gastric electrical stimulation. Rev Endocr Metab Disord. 2016.
19.
Hollands GJ, French DP, Griffin SJ, Prevost AT, Sutton S, King S, et al. The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis. BMJ. 2016;352:i1102.CrossRefPubMedPubMedCentral
20.
Malin SK, Liu Z, Barrett EJ, Weltman A. Exercise resistance across the prediabetes phenotypes: impact on insulin sensitivity and substrate metabolism. Rev Endocr Metab Disord. 2016.
21.
Monnier L, Colette C, Dejager S, Owens DR. Near normal HbA1c with stable glucose homeostasis: the ultimate target / aim of diabetes therapy. Rev Endocr Metab Disord. 2016.
22.
Škrha J, Šoupal J, Škrha J Jr, Prázný M. Glucose variability, HbA1c and microvascular complications. Rev Endocr Metab Disord. 2016.
23.
Ceriello A, Genovese SA. Atherogenicity of postprandial hyperglycemia and lipotoxiticy. Rev Endocr Metab Disord. 2016.
24.
Cahn A, Cernea S, Raz I. Outcome studies and safety as guide for decision making in treating patients with type 2 diabetes. Rev Endocr Metab Disord. 2016.
25.
Engelmann J, Manuwald U, Rubach C, Kugler J, Birkenfeld AL, Hanefeld M, et al. Determinants of mortality in patients with type 2 diabetes: a review. Rev Endocr Metab Disord. 2016.
Metadata
Title
Introduction to Hanefeld Symposium: 40+ years of metabolic syndrome
Authors
Christian A. Koch
Stefan R. Bornstein
Andreas L. Birkenfeld
Publication date
01-03-2016
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 1/2016
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-016-9356-1

Other articles of this Issue 1/2016

Reviews in Endocrine and Metabolic Disorders 1/2016 Go to the issue

ReviewPaper

Interventional treatment of obesity and diabetes: An interim report on gastric electrical stimulation

ReviewPaper

The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH)

ReviewPaper

The role of innate immunity in the regulation of brown and beige adipogenesis

ReviewPaper

Atherogenicity of postprandial hyperglycemia and lipotoxicity

ReviewPaper

Exercise resistance across the prediabetes phenotypes: Impact on insulin sensitivity and substrate metabolism

ReviewPaper

Glucose variability, HbA1c and microvascular complications
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits